Insider Transactions Reported by 23 Insiders of MBX Biosciences, Inc.

Symbol
MBX on Nasdaq
Location
Carmel, IN

Insiders trading volume in the past year

MBX Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Patrick J. Heron Director, 10%+ Owner $93,949,920 +$11,999,988 +15% 26 Sep 2025
Frazier Life Sciences X, L.P. 10%+ Owner $48,669,154 16 Sep 2024
Ali Behbahani 10%+ Owner $38,638,855 16 Sep 2024
Edward T. Mathers Director, 10%+ Owner $38,638,855 05 Jun 2025
SCOTT D. SANDELL 10%+ Owner $38,638,855 16 Sep 2024
Paul Edward Walker 10%+ Owner $38,638,855 16 Sep 2024
Rick Yang 10%+ Owner $38,638,855 16 Sep 2024
Anthony A. Florence Jr. 10%+ Owner $38,638,855 16 Sep 2024
Carmen Chang 10%+ Owner $38,638,855 16 Sep 2024
New Enterprise Associates 17, L.P. 10%+ Owner $38,638,855 16 Sep 2024
FOREST BASKETT 10%+ Owner $38,638,855 16 Sep 2024
Mohamad Makhzoumi 10%+ Owner $38,638,855 16 Sep 2024
Tiba Aynechi Director $22,837,421 05 Jun 2025
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10%+ Owner $19,136,404 16 Sep 2024
P. Kent Hawryluk President & CEO, Director $10,353,679 +$807,290 +8.5% 24 Oct 2025
ORBIMED ADVISORS LLC Director, 10%+ Owner $8,107,095 +$2,020,756 +33% 14 Feb 2025
CARL L. GORDON Director, 10%+ Owner $8,107,095 +$2,020,756 +33% 14 Feb 2025
JAMES M. CORNELIUS Director $1,091,257 05 Jun 2025
Steven L. Hoerter Director $264,984 +$264,984 22 Nov 2025
Ora H. Pescovitz Director $143,298 +$45,312 +46% 05 Jun 2025
Salomon Azoulay Chief Medical Officer 03 Feb 2025
Steven Ryder Director 05 Jun 2025
Richard Bartram Chief Financial Officer 03 Feb 2025

Recent Insider Transactions by Companies or Individuals for MBX Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.